[Prevention of hepatitis B transmission during the delivery in Picardy (2006)].
OBJECTIVE
No French publication is available to assess the prevention of the hepatitis B transmission during delivery. The aim of this study was to evaluate the traceability and the compliance with the guidelines for administration of hepatitis B immune globulin (Ig) in public and private maternities of Picardy.


METHODS
We obtained the files of the mothers who were likely to be HBsAg + by a query in the medico-administrative data base (PMSI). Newborns who received hepatitis B Ig were obtained by the pharmacies and the obstetrical wards's registers and a PMSI query.


RESULTS
Nineteen of 20 maternities participated to the study. One hundred and forty five files were identified (65 mothers HBsAg +, 75 HBsAg -, 5 unknown) and 81 hepatitis B Ig injections were rated in the file and 5 unrated. Twenty percent of the rated Ig injections (16/81) were not pertinent (new born from HbsAg - mothers). Dose complied with the guidelines (100 UI) in 85 % of cases and the schedule (within the 12 first hours after delivery) in 79 %. The traceability was present in 69 % of the files. As a whole, only 40 % (32/81) of Ig injections follow the guidelines indications (indication, recommended dose and time, traceability). A letter (for general practitioner, pediatrician or hepatologist) for follow up of the baby or/and the mother was found in 40 files out of 145.


CONCLUSIONS
The prevention of the hepatitis B transmission during the delivery must be improved through a national strategy with a multi-professional mobilisation plus a local implementation.
Lerat
Anne
A
CHU d'Amiens, Santé publique, 80054 Amiens cedex 1, France.
Braillon
Alain
A
Capron
Dominique
D
Tiberghien
Jean-Pierre
JP
Dubois
Gérard
G
D003430:Cross-Sectional Studies; D036861:Delivery, Obstetric; D005602:France; D019983:Guideline Adherence; D006509:Hepatitis B / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*
D007136:Immunoglobulins